Danone Offers $307M for Lifeway Foods kefir.

Dairy giant Danone has increased its bid to acquire all remaining shares of kefir-maker Lifeway Foods, signaling its confidence in the company’s potential.

The revised offer of $27 per share, valued at approximately $307 million, was disclosed in a recent regulatory filing. This comes after Danone’s initial bid of $25 per share (or $283 million) in September was met with resistance from Lifeway’s board.

Danone’s Strategy A Push for Growth

Danone owns 23.3% of Lifeway’s common shares, a stake it has acquired over the past two decades. His move to fully acquire Lifeway aligns with Danone’s strategy to expand its portfolio of better-for-you dairy products, which are in high demand among health-conscious consumers.

Lifeway, known for its kefir and probiotic-rich fermented beverages, has consistently performed well. The company reported $46.1 million in net sales for the third quarter ending September 30, reflecting a year-over-year growth of $5.2 million.

This marks Lifeway’s 20th consecutive quarter of growth, highlighting its consistent appeal in the health food market.

Why Lifeway is a Valuable Target

Lifeway Foods has built its brand on delivering nutritious, fermented dairy products like kefir, which resonate with the growing demand for functional foods. The company’s success is rooted in its ability to stay relevant in the health and wellness trend.

As a significant shareholder, Danone recognizes Lifeway’s long-term potential and sees the acquisition as a way to remove the challenges of being a publicly traded company. In its proposal, Danone stated:

“We believe Lifeway has an attractive opportunity to achieve its full potential through a combination with Danone, removing constraints and providing additional resources.”

Lifeway’s Response A Careful Consideration

Lifeway’s board has yet to accept Danone’s revised offer. The company noted that it would review and evaluate the updated proposal to ensure it aligns with the best interests of shareholders, stakeholders, and employees.

This cautious approach isn’t surprising. Lifeway has faced pressure from various stakeholders to maximize value, especially after rejecting the initial offer.

Shareholder Influence and Internal Disputes

A family dispute involving Lifeway’s CEO Julie Smolyansky and her relatives is adding complexity to the situation. Her brother and mother, Edward and Ludmila Smolyansky, have publicly supported Danone’s acquisition proposal.

In a letter, they urged the board to seize the opportunity, stating:

“The longer they wait, the more money they will leave on the table, to the detriment of all.”

This internal disagreement may push the board toward accepting the deal, especially as Kanen Wealth Management, a major shareholder, had previously called Lifeway’s stock undervalued and advocated for a sale.

Challenges and Next Steps

While Danone’s revised offer adds $2 per share to its initial bid, whether this will satisfy Lifeway’s board is still being determined. However, with Danone already owning nearly a quarter of the company, the likelihood of another bidder stepping in is slim.

Danone emphasized its readiness to move forward, stating:

“We would welcome the opportunity to discuss this Updated Proposal and next steps with you.”

A Promising Future for Lifeway with Danone

Lifeway could benefit from Danone’s global resources, marketing expertise, and distribution network if the acquisition goes through. This would allow the kefir maker to expand its reach and solidify its position as a leader in the functional food industry.

Conclusion

Danone’s potential acquisition of Lifeway Foods represents a significant opportunity for both companies. For Danone, it’s a chance to strengthen its foothold in the health and wellness market, while for Lifeway, the partnership could unlock new growth avenues.

As the board deliberates over the revised offer, the future of this acquisition hangs in the balance. Regardless of the outcome, Lifeway’s track record and position in the probiotic beverage industry make it a valuable player in today’s competitive market.

FAQs

READ MORE: McDonald’s is Spending $100 Million to Get Back Consumers Following E. Coli.